查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1916293

输液袋市场按产品类型、包装材料、容量、最终用户和分销管道划分－2026-2032年全球预测

IV Fluid Bags Market by Product Type, Packaging Material, Bag Volume, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，输液袋市场价值将达到 72.5 亿美元，到 2026 年将成长至 76.7 亿美元，到 2032 年将达到 121.5 亿美元，年复合成长率为 7.65%。

关键市场统计数据
基准年 2025 72.5亿美元
预计年份：2026年 76.7亿美元
预测年份 2032 121.5亿美元
复合年增长率 (%) 7.65%

全面了解不断发展的静脉输液袋领域，其中临床需求、供应稳定性以及材料创新正在重新定义策略重点。

静脉输液袋领域正处于一个关键的转折点，临床需求、不断变化的法规和材料创新在此交汇融合，重塑供应商的策略和采购行为。临床医生在选择配方和包装形式时，始终将患者安全和适用性放在首位。同时，采购和供应链团队必须平衡这些临床需求与对材料永续性和一次性医疗器材管理日益严格的审查。此外，製造商也在调整其生产布局和技术架构，以服务更广泛的终端用户群体，从高风险重症医院到居家医疗机构。

材料替代、分散式照护环境、永续性优先事项和供应链重组如何共同改变静脉输液袋策略

受材料替代、监管压力和临床护理环境重塑的驱动，静脉输液袋市场环境正经历多重变化。首先，传统的PVC包装正明显转向非PVC替代品。这主要得益于生物聚合物薄膜和乙烯-醋酸乙烯酯共聚物（EVA）技术的进步，这些技术有望提高安全性并减少可萃取物。这种材料转变正在影响配方相容性、灭菌方法和生产工具，从而推动资本投资和新的供应商伙伴关係。

评估 2025 年美国关税政策对输液袋的采购、製造在地化和供应链韧性的多面向连锁反应。

美国关税将于2025年生效，对输液袋的采购、生产和全球分销管道产生了复杂的连锁反应。在采购层面，关税带来的成本压力迫使采购商重新评估其供应商组合，并考虑优先考虑降低关税负担的替代筹资策略。为此，供应链团队正在加快对本地及週边製造商的资质认证，并加强长期合约、避险和供应商管理库存（VMI）等事宜的谈判，以降低价格波动风险。

一个整合的细分框架，将製剂分类、临床应用、包装材料、容量通路和分销管道与营运和临床决策驱动因素连结起来。

透过精细的市场区隔方法，可以清楚地揭示输液袋市场的需求驱动因素和技术限制，从而指导产品开发、商业化和筹资策略。依产品类型，此市场可分为胶体和晶体两大类。胶体包括白蛋白、聚葡萄糖、明胶和羟乙基淀粉，每种胶体都有其独特的临床适应症和稳定性考虑；晶体包括葡萄糖、生理食盐水水和乳酸林格氏液，这些都是復苏和常规维持治疗的基础。这种产品细分决定了不同输液袋材料和灭菌方法的配方相容性，进而影响包装选择和监管文件。

美洲、欧洲、中东和非洲以及亚太地区的区域趋势和监管环境将决定供应策略、采用模式和合规方法。

区域趋势将对输液袋的供应韧性、监管路径和市场接受度产生决定性影响，进而影响生产商和采购商的策略重点。在美洲，先进的医院网路和大规模综合医疗保健系统对各种配方和容量的输液袋产生了集中需求，而区域供应商和契约製造製造商则致力于满足严格的监管和品质要求。该地区也出现了永续性标准加速普及和产品责任延伸计画不断扩大的趋势，这将影响包装材料的选择和处置方式。

静脉输液袋市场竞争格局：规模、材料创新、监管应对力和灵活的区域供应模式将决定市场领导地位的趋势

输液袋市场的竞争格局取决于产品创新、生产规模、通路和监管能力。成熟的跨国製造商在检验的生产流程、全球监管文件和广泛的分销网络方面拥有优势，使其能够服务复杂的医院系统和大型采购集团。同时，专业的区域供应商和契约製造製造商则提供灵活性和本地化应对力，通常能够帮助寻求关税减免或近岸采购的医疗系统加快认证週期。

为确保供应韧性、检验替代材料以及调整产品系列以适应分散式医疗保健服务，製造商和负责人可采取切实可行的、优先考虑的策略行动。

产业领导者应采取多管齐下的策略，将临床优先事项与稳健的供应链设计和材料创新相结合。首先，透过与临床合作伙伴和输液设备供应商合格进行检验项目，加速非PVC包装方案的认证，以证明其在常用给药系统中的兼容性、无菌性和临床安全性。这将降低采用门槛，并使供应商能够满足日益增长的永续性和安全性要求。其次，实现製造地多元化，纳入近岸和区域性选项，以便快速应对关税波动和物流中断。同时，维持品质系统的一致性和重点监管至关重要。

我们采用了严谨的混合调查方法，结合了关键相关人员访谈、设施检验、技术文献综述和情境分析，以提供可靠的策略见解。

我们的研究途径整合了定性和定量证据，旨在对输液袋市场趋势形成切实可行的理解。主要研究包括对采购主管、临床药师、法规事务专家和生产主管进行结构化访谈，以收集有关供应链脆弱性、材料偏好和实施障碍的第一手观点。此外，我们也结合了生产和包装设施的现场考察和流程审核，以检验生产流程和品管措施。

从策略层面整合关键的临床、材料和供应链问题，以确定输液解决方案可持续取得和创新的可行优先事项。

总而言之，在材料创新、医疗服务模式变革、永续性以及贸易政策趋势等多重压力下，静脉输液袋产业正在不断发展。这些因素迫使製造商重新思考包装材料，调整製造地，并加强与临床和采购相关人员的合作。同时，买家要求提高材料透明度、无菌保证以及全生命週期影响的透明度，这凸显了检验的非PVC解决方案和灵活的分销模式对于支持门诊和居家医疗的重要性。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 依产品类型分類的输液袋市场

  • 胶体
    • 白蛋白
    • 聚葡萄糖
    • 明胶
    • 羟乙基淀粉
  • 晶体溶液
    • 葡萄糖
    • 生理食盐水
    • 林格氏乳酸盐溶液

9. 按包装材料分類的输液袋市场

  • 不含聚氯乙烯
    • 生物聚合物薄膜
    • 乙烯-醋酸乙烯酯
  • PVC

第十章 依输液袋容量分類的输液袋市场

  • 100～250 mL
  • 250-500 mL
  • 500～1000 mL
  • 超过1000毫升

第十一章 依终端用户分類的输液袋市场

  • 门诊手术中心
  • 诊所
  • 居家医疗
  • 医院

第十二章 按分销管道分類的输液袋市场

  • 医院药房
  • 网路药房
  • 零售药房

第十三章 输液袋市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 输液袋市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国输液袋市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章美国输液袋市场

第十七章 中国输液袋市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Amcor Limited
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Fresenius Kabi AG
  • Grifols, SA
  • Hikma Pharmaceuticals PLC
  • ICU Medical, Inc.
  • Kraton Corporation
  • Nipro Corporation
  • Otsuka Pharmaceutical Co., Ltd.
  • Pfizer Inc.
  • Terumo Corporation
  • Wipak Group
Product Code: MRR-AE420CB1535B

The IV Fluid Bags Market was valued at USD 7.25 billion in 2025 and is projected to grow to USD 7.67 billion in 2026, with a CAGR of 7.65%, reaching USD 12.15 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 7.25 billion
Estimated Year [2026] USD 7.67 billion
Forecast Year [2032] USD 12.15 billion
CAGR (%) 7.65%

A comprehensive orientation to the evolving intravenous fluid bag domain where clinical imperatives, supply resilience, and material innovation are redefining strategic priorities

The intravenous fluid bag sector is at a pivotal intersection where clinical demand, regulatory evolution, and materials innovation converge to reshape supplier strategies and procurement behavior. Clinicians continue to prioritize patient safety and compatibility when selecting formulations and packaging formats, while procurement and supply-chain teams must reconcile these clinical needs with rising scrutiny around material sustainability and single-use device stewardship. In parallel, manufacturers are adapting production footprints and technology stacks to serve a more diversified set of end users, from high-acuity hospitals to home healthcare settings.

Consequently, stakeholders across the value chain face a broadened decision horizon: procurement teams must assess total lifecycle impacts and compatibility with infusion systems, clinical teams must balance therapeutic profiles with fluid selection protocols, and regulatory affairs groups must navigate a tightening framework for device and packaging approval. Moreover, the industry landscape is being influenced by raw material availability and environmental concerns that accelerate the shift toward alternative polymers. As a result, strategic clarity is now a competitive differentiator; organizations that translate operational resilience, material science, and clinical alignment into pragmatic product and supply strategies will be best positioned to navigate near-term disruptions and longer-term structural shifts.

How material substitution, care-setting decentralization, sustainability priorities, and supply-chain realignment are jointly transforming intravenous fluid bag strategies

The landscape for intravenous fluid bags is undergoing several transformative shifts driven by material substitution, regulatory pressure, and a reconfiguration of clinical care settings. First, there is a clear movement away from legacy PVC-based packaging toward non-PVC alternatives, led by advances in biopolymer films and ethylene vinyl acetate technologies that promise improved safety profiles and reduced leachables. This material transition is affecting formulation compatibility, sterilization practices, and production tooling, prompting capital investments and new vendor partnerships.

Second, the distribution and point-of-care paradigm is diversifying as ambulatory surgical centers and home healthcare expand their utilization of intravenous therapies. This change compels manufacturers to offer a broader range of bag volumes and packaging formats that support safe administration outside of traditional inpatient settings. Third, environmental and sustainability metrics are increasingly embedded into procurement criteria, influencing purchasing decisions and supplier scorecards. Finally, geopolitical dynamics and trade policy shifts are accelerating supply-chain reconfiguration, creating opportunities for regional manufacturing hubs and contract manufacturing specialization. Taken together, these shifts are not isolated; they interact to drive R&D priorities, influence clinical protocols, and create new criteria for supplier selection that favor adaptable, compliance-ready partners.

Assessing the multifaceted ripple effects of 2025 United States tariff policies on procurement, manufacturing localization, and supply-chain resiliency for intravenous fluid bags

United States tariff measures implemented in 2025 have introduced a complex set of cascading effects that extend across procurement, manufacturing, and global distribution channels for intravenous fluid bags. On a procurement level, tariff-induced cost pressures have forced buyers to reassess supplier portfolios and evaluate alternative sourcing strategies that prioritize tariff exposure minimization. In response, supply teams have accelerated qualification of regional and nearshore manufacturers and intensified negotiations around long-term agreements, hedging, and vendor-managed inventory arrangements to mitigate volatility.

At the manufacturing level, tariffs have prompted a renewed focus on localization and vertically integrated supply models. Manufacturers are evaluating the trade-offs between relocating final assembly versus reshaping upstream supply chains for polymers and additives to reduce tariff incidence. This has also sharpened interest in contract manufacturing partners with multi-jurisdictional footprints that can shift production with limited disruption. Furthermore, tariff-driven cost dynamics have catalyzed innovation in materials efficiency and packaging design to preserve margins without sacrificing clinical performance.

Regulatory and procurement teams have felt indirect impacts, as cost pass-through pressures intersect with hospital budgeting cycles and reimbursement frameworks. This convergence has increased scrutiny of total cost of ownership calculations and the operational implications of switching packaging types or suppliers. In sum, tariff policies have accelerated strategic planning horizons, encouraged diversification of supply chains, and reinforced the importance of resilient procurement solutions that integrate material, regulatory, and logistical considerations into sourcing decisions.

Integrated segmentation framework linking formulation classes, care settings, packaging materials, volume ranges, and distribution channels to operational and clinical decision drivers

A refined segmentation approach reveals distinct demand drivers and technical constraints that inform product development, commercialization, and procurement strategies across the intravenous fluid bag landscape. Based on product type, the domain divides into colloid and crystalloid formulations; colloids encompass albumin, dextrans, gelatins, and hydroxyethyl starch, each with unique clinical indications and stability considerations, while crystalloids include dextrose, normal saline, and Ringer's lactate, which are foundational to resuscitation and routine maintenance therapies. This product segmentation dictates formulation compatibility with different bag materials and sterilization regimes, thereby influencing packaging choices and regulatory documentation.

Based on end user, demand profiles vary significantly across ambulatory surgical centers, clinics, home healthcare, and hospitals, with each setting exhibiting distinct volume rhythms, handling practices, and storage constraints that shape bag volume preferences and distribution models. Based on packaging material, the industry is bifurcated into non-PVC and PVC options; the non-PVC cohort further comprises biopolymer films and ethylene vinyl acetate, which present advantages for reducing plasticizer exposure and improving environmental credentials but require adaptation in manufacturing processes and supplier assurance programs.

Based on bag volume, product offerings span ranges from 100-250 mL to 250-500 mL, 500-1000 mL, and volumes above 1000 mL, with clinical protocols and point-of-care settings driving preferred sizes. Lastly, based on distribution channel, product availability and purchasing behavior are shaped by hospital pharmacy, online pharmacy, and retail pharmacy routes that impose different regulatory, packaging, and logistics requirements. Integrating these segmentation lenses enables a differentiated approach to portfolio design, inventory management, and clinical engagement strategies.

Regional dynamics and regulatory landscapes across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine supply strategies, adoption patterns, and compliance approaches

Regional dynamics exert a decisive influence on supply resilience, regulatory pathways, and adoption curves for intravenous fluid bags, shaping strategic priorities across manufacturers and buyers. In the Americas, advanced hospital networks and large integrated health systems create concentrated demand for a broad range of formulations and volumes, while regional suppliers and contract manufacturers work to meet stringent regulatory and quality expectations. This region also exhibits accelerated adoption of sustainability criteria and extended product stewardship programs that influence packaging material choices and end-of-life considerations.

Europe, Middle East & Africa present a heterogeneous landscape where regulatory harmonization in some jurisdictions coexists with fragmented procurement practices in others, requiring manufacturers to engage in nuanced market access strategies. In these markets, stakeholder expectations around patient safety, material biocompatibility, and local manufacturing content influence both clinical adoption and purchasing decisions. Meanwhile, the Asia-Pacific region is characterized by dynamic capacity expansion, diverse clinical infrastructures, and rapid uptake of home healthcare services, driving demand for varied bag volumes and adaptable packaging solutions; local production capabilities and government procurement policies also play a pivotal role in shaping competitive positioning. Across these geographies, differing regulatory timelines, supply-chain architectures, and sustainability mandates necessitate region-specific commercialization, manufacturing, and supply strategies to ensure timely access and compliance.

Competitive anatomy of the intravenous fluid bag arena where scale, material innovation, regulatory expertise, and agile regional supply models determine market leadership dynamics

Competitive dynamics in the intravenous fluid bag space are shaped by product innovation, manufacturing scale, distribution breadth, and regulatory competency. Established multinational manufacturers maintain advantages in validated production processes, global regulatory dossiers, and broad distribution networks, enabling them to serve complex hospital systems and large procurement groups. At the same time, specialized regional suppliers and contract manufacturers provide agility and localized responsiveness, often supporting rapid qualification cycles for health systems seeking reduced tariff exposure or nearshore sourcing.

Innovation is concentrated not only in formulation optimization but also in packaging and sterilization technology, where advancements in non-PVC biopolymer films and ethylene vinyl acetate materials have created distinct product families that appeal to safety- and sustainability-driven buyers. Strategic partnerships and co-development agreements between material science firms and infusion device manufacturers are increasingly common as firms seek to validate compatibility across administration sets and infusion pumps. Additionally, private-label and private-brand strategies adopted by large health systems and pharmacy groups are influencing demand patterns, pressuring traditional suppliers to offer differentiated service models, value-added logistics, and bundled clinical support. Overall, success in this environment favors companies that combine technical excellence, regulatory rigor, flexible manufacturing footprints, and deep engagement with clinical and procurement stakeholders.

Practical, prioritized strategic actions for manufacturers and buyers to secure supply resilience, validate alternative materials, and align product portfolios with decentralized care delivery

Industry leaders should pursue a multifaceted strategy that aligns clinical priorities with resilient supply-chain design and material innovation. First, accelerate qualification of non-PVC packaging options by investing in joint validation programs with clinical partners and infusion device vendors to demonstrate compatibility, sterility retention, and clinical safety across common administration systems. This will reduce adoption friction and position suppliers to meet growing sustainability and safety requirements. Second, diversify manufacturing footprints to include nearshore and regional options that can be scaled rapidly in response to tariff shifts or logistic interruptions, while maintaining consistent quality systems and centralized regulatory oversight.

Third, establish integrated procurement solutions that combine long-term supply agreements with flexible volume commitments and vendor-managed inventory models to smooth demand variability across ambulatory centers, hospitals, and home healthcare channels. Fourth, enhance engagement with hospital pharmacy and outpatient pharmacy stakeholders by offering tailored packaging volumes and educational initiatives that support safe handling in decentralized care settings. Fifth, invest in traceability and lifecycle assessment capabilities to provide purchasers with transparent data on material composition, sterilization validation, and end-of-life disposal options, thereby aligning with evolving procurement criteria. Finally, prioritize collaborative R&D with material science partners to improve polymer performance and reduce dependence on constrained raw materials, thereby protecting margins and enabling continuous product innovation.

A rigorous mixed-methods research approach combining primary stakeholder interviews, facility validation, technical literature review, and scenario analysis for dependable strategic insights

The research approach combined qualitative and quantitative evidence streams to develop robust, actionable insight into intravenous fluid bag dynamics. Primary research included structured interviews with procurement leaders, clinical pharmacists, regulatory affairs professionals, and manufacturing executives to capture first-hand perspectives on supply-chain vulnerabilities, material preferences, and adoption barriers. These interviews were complemented by site visits and process audits at manufacturing and packaging facilities to validate production workflows and quality management practices.

Secondary research focused on regulatory guidance, published clinical literature, and materials science studies to assess compatibility considerations and safety profiles for different polymers and formulations. Data triangulation was applied to reconcile primary observations with published technical evidence and supplier disclosures, ensuring conclusions reflected both market practice and technical feasibility. Scenario analysis was used to model the operational impacts of tariff policies, material supply interruptions, and shifts in care delivery, enabling the development of practical mitigation pathways. Finally, validation workshops with cross-functional stakeholders refined recommendations and ensured that proposed actions were operationally and clinically feasible within existing procurement and regulatory frameworks.

Strategic synthesis of clinical, material, and supply-chain imperatives that defines the actionable priorities for sustained access and innovation in intravenous fluid solutions

In summary, the intravenous fluid bag domain is evolving under the combined pressures of material innovation, shifting care delivery models, sustainability mandates, and trade policy dynamics. These forces are prompting manufacturers to rethink packaging materials, adjust manufacturing footprints, and deepen engagement with clinical and procurement stakeholders. At the same time, buyers are demanding greater transparency around materials, sterility assurance, and total lifecycle implications, which is elevating the importance of validated non-PVC solutions and flexible distribution models that support ambulatory and home-based care.

Going forward, success will depend on the ability of organizations to integrate clinical validation, regulatory readiness, and supply-chain resilience into coherent commercialization and sourcing strategies. Those that proactively qualify alternative materials, diversify production geographies, and provide clear evidence of compatibility and environmental performance will reduce operational risk and better meet the evolving priorities of health systems. Ultimately, the most effective responses will be collaborative, balancing technical innovation with pragmatic supply arrangements and targeted clinical engagement to ensure safe and reliable access to intravenous therapies.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. IV Fluid Bags Market, by Product Type

  • 8.1. Colloid
    • 8.1.1. Albumin
    • 8.1.2. Dextrans
    • 8.1.3. Gelatins
    • 8.1.4. Hydroxyethyl Starch
  • 8.2. Crystalloid
    • 8.2.1. Dextrose
    • 8.2.2. Normal Saline
    • 8.2.3. Ringers Lactate

9. IV Fluid Bags Market, by Packaging Material

  • 9.1. Non-PVC
    • 9.1.1. Biopolymer Films
    • 9.1.2. Ethylene Vinyl Acetate
  • 9.2. PVC

10. IV Fluid Bags Market, by Bag Volume

  • 10.1. 100-250 mL
  • 10.2. 250-500 mL
  • 10.3. 500-1000 mL
  • 10.4. Above 1000 mL

11. IV Fluid Bags Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Clinics
  • 11.3. Home Healthcare
  • 11.4. Hospitals

12. IV Fluid Bags Market, by Distribution Channel

  • 12.1. Hospital Pharmacy
  • 12.2. Online Pharmacy
  • 12.3. Retail Pharmacy

13. IV Fluid Bags Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. IV Fluid Bags Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. IV Fluid Bags Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States IV Fluid Bags Market

17. China IV Fluid Bags Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Amcor Limited
  • 18.6. B. Braun Melsungen AG
  • 18.7. Baxter International Inc.
  • 18.8. Fresenius Kabi AG
  • 18.9. Grifols, S.A.
  • 18.10. Hikma Pharmaceuticals PLC
  • 18.11. ICU Medical, Inc.
  • 18.12. Kraton Corporation
  • 18.13. Nipro Corporation
  • 18.14. Otsuka Pharmaceutical Co., Ltd.
  • 18.15. Pfizer Inc.
  • 18.16. Terumo Corporation
  • 18.17. Wipak Group

LIST OF FIGURES

  • FIGURE 1. GLOBAL IV FLUID BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL IV FLUID BAGS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL IV FLUID BAGS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL IV FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL IV FLUID BAGS MARKET SIZE, BY BAG VOLUME, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL IV FLUID BAGS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL IV FLUID BAGS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL IV FLUID BAGS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL IV FLUID BAGS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES IV FLUID BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA IV FLUID BAGS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL IV FLUID BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL IV FLUID BAGS MARKET SIZE, BY COLLOID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL IV FLUID BAGS MARKET SIZE, BY COLLOID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL IV FLUID BAGS MARKET SIZE, BY COLLOID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL IV FLUID BAGS MARKET SIZE, BY COLLOID, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL IV FLUID BAGS MARKET SIZE, BY ALBUMIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL IV FLUID BAGS MARKET SIZE, BY ALBUMIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL IV FLUID BAGS MARKET SIZE, BY ALBUMIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL IV FLUID BAGS MARKET SIZE, BY DEXTRANS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL IV FLUID BAGS MARKET SIZE, BY DEXTRANS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL IV FLUID BAGS MARKET SIZE, BY DEXTRANS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL IV FLUID BAGS MARKET SIZE, BY GELATINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL IV FLUID BAGS MARKET SIZE, BY GELATINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL IV FLUID BAGS MARKET SIZE, BY GELATINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL IV FLUID BAGS MARKET SIZE, BY HYDROXYETHYL STARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL IV FLUID BAGS MARKET SIZE, BY HYDROXYETHYL STARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL IV FLUID BAGS MARKET SIZE, BY HYDROXYETHYL STARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL IV FLUID BAGS MARKET SIZE, BY CRYSTALLOID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL IV FLUID BAGS MARKET SIZE, BY CRYSTALLOID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL IV FLUID BAGS MARKET SIZE, BY CRYSTALLOID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL IV FLUID BAGS MARKET SIZE, BY CRYSTALLOID, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL IV FLUID BAGS MARKET SIZE, BY DEXTROSE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL IV FLUID BAGS MARKET SIZE, BY DEXTROSE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL IV FLUID BAGS MARKET SIZE, BY DEXTROSE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL IV FLUID BAGS MARKET SIZE, BY NORMAL SALINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL IV FLUID BAGS MARKET SIZE, BY NORMAL SALINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL IV FLUID BAGS MARKET SIZE, BY NORMAL SALINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL IV FLUID BAGS MARKET SIZE, BY RINGERS LACTATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL IV FLUID BAGS MARKET SIZE, BY RINGERS LACTATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL IV FLUID BAGS MARKET SIZE, BY RINGERS LACTATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL IV FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL IV FLUID BAGS MARKET SIZE, BY NON-PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL IV FLUID BAGS MARKET SIZE, BY NON-PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL IV FLUID BAGS MARKET SIZE, BY NON-PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL IV FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL IV FLUID BAGS MARKET SIZE, BY BIOPOLYMER FILMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL IV FLUID BAGS MARKET SIZE, BY BIOPOLYMER FILMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL IV FLUID BAGS MARKET SIZE, BY BIOPOLYMER FILMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL IV FLUID BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL IV FLUID BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL IV FLUID BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL IV FLUID BAGS MARKET SIZE, BY PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL IV FLUID BAGS MARKET SIZE, BY PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL IV FLUID BAGS MARKET SIZE, BY PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL IV FLUID BAGS MARKET SIZE, BY BAG VOLUME, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL IV FLUID BAGS MARKET SIZE, BY 100-250 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL IV FLUID BAGS MARKET SIZE, BY 100-250 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL IV FLUID BAGS MARKET SIZE, BY 100-250 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL IV FLUID BAGS MARKET SIZE, BY 250-500 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL IV FLUID BAGS MARKET SIZE, BY 250-500 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL IV FLUID BAGS MARKET SIZE, BY 250-500 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL IV FLUID BAGS MARKET SIZE, BY 500-1000 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL IV FLUID BAGS MARKET SIZE, BY 500-1000 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL IV FLUID BAGS MARKET SIZE, BY 500-1000 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL IV FLUID BAGS MARKET SIZE, BY ABOVE 1000 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL IV FLUID BAGS MARKET SIZE, BY ABOVE 1000 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL IV FLUID BAGS MARKET SIZE, BY ABOVE 1000 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL IV FLUID BAGS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL IV FLUID BAGS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL IV FLUID BAGS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL IV FLUID BAGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL IV FLUID BAGS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL IV FLUID BAGS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL IV FLUID BAGS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL IV FLUID BAGS MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL IV FLUID BAGS MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL IV FLUID BAGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL IV FLUID BAGS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL IV FLUID BAGS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL IV FLUID BAGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL IV FLUID BAGS MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL IV FLUID BAGS MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL IV FLUID BAGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL IV FLUID BAGS MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL IV FLUID BAGS MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL IV FLUID BAGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL IV FLUID BAGS MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL IV FLUID BAGS MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL IV FLUID BAGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS IV FLUID BAGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS IV FLUID BAGS MARKET SIZE, BY COLLOID, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS IV FLUID BAGS MARKET SIZE, BY CRYSTALLOID, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS IV FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS IV FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS IV FLUID BAGS MARKET SIZE, BY BAG VOLUME, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA IV FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA IV FLUID BAGS MARKET SIZE, BY COLLOID, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA IV FLUID BAGS MARKET SIZE, BY CRYSTALLOID, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA IV FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA IV FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA IV FLUID BAGS MARKET SIZE, BY BAG VOLUME, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA IV FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA IV FLUID BAGS MARKET SIZE, BY COLLOID, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA IV FLUID BAGS MARKET SIZE, BY CRYSTALLOID, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA IV FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA IV FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA IV FLUID BAGS MARKET SIZE, BY BAG VOLUME, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA IV FLUID BAGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA IV FLUID BAGS MARKET SIZE, BY COLLOID, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA IV FLUID BAGS MARKET SIZE, BY CRYSTALLOID, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA IV FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA IV FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA IV FLUID BAGS MARKET SIZE, BY BAG VOLUME, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE IV FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE IV FLUID BAGS MARKET SIZE, BY COLLOID, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE IV FLUID BAGS MARKET SIZE, BY CRYSTALLOID, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE IV FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE IV FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE IV FLUID BAGS MARKET SIZE, BY BAG VOLUME, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST IV FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST IV FLUID BAGS MARKET SIZE, BY COLLOID, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST IV FLUID BAGS MARKET SIZE, BY CRYSTALLOID, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST IV FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST IV FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST IV FLUID BAGS MARKET SIZE, BY BAG VOLUME, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA IV FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA IV FLUID BAGS MARKET SIZE, BY COLLOID, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA IV FLUID BAGS MARKET SIZE, BY CRYSTALLOID, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA IV FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA IV FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA IV FLUID BAGS MARKET SIZE, BY BAG VOLUME, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC IV FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC IV FLUID BAGS MARKET SIZE, BY COLLOID, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC IV FLUID BAGS MARKET SIZE, BY CRYSTALLOID, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC IV FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC IV FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC IV FLUID BAGS MARKET SIZE, BY BAG VOLUME, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL IV FLUID BAGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN IV FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN IV FLUID BAGS MARKET SIZE, BY COLLOID, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN IV FLUID BAGS MARKET SIZE, BY CRYSTALLOID, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN IV FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN IV FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN IV FLUID BAGS MARKET SIZE, BY BAG VOLUME, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. GCC IV FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. GCC IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. GCC IV FLUID BAGS MARKET SIZE, BY COLLOID, 2018-2032 (USD MILLION)
  • TABLE 168. GCC IV FLUID BAGS MARKET SIZE, BY CRYSTALLOID, 2018-2032 (USD MILLION)
  • TABLE 169. GCC IV FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 170. GCC IV FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 171. GCC IV FLUID BAGS MARKET SIZE, BY BAG VOLUME, 2018-2032 (USD MILLION)
  • TABLE 172. GCC IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. GCC IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION IV FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION IV FLUID BAGS MARKET SIZE, BY COLLOID, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION IV FLUID BAGS MARKET SIZE, BY CRYSTALLOID, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION IV FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION IV FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION IV FLUID BAGS MARKET SIZE, BY BAG VOLUME, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS IV FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS IV FLUID BAGS MARKET SIZE, BY COLLOID, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS IV FLUID BAGS MARKET SIZE, BY CRYSTALLOID, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS IV FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS IV FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS IV FLUID BAGS MARKET SIZE, BY BAG VOLUME, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 192. G7 IV FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. G7 IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. G7 IV FLUID BAGS MARKET SIZE, BY COLLOID, 2018-2032 (USD MILLION)
  • TABLE 195. G7 IV FLUID BAGS MARKET SIZE, BY CRYSTALLOID, 2018-2032 (USD MILLION)
  • TABLE 196. G7 IV FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 197. G7 IV FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 198. G7 IV FLUID BAGS MARKET SIZE, BY BAG VOLUME, 2018-2032 (USD MILLION)
  • TABLE 199. G7 IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. G7 IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 201. NATO IV FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. NATO IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. NATO IV FLUID BAGS MARKET SIZE, BY COLLOID, 2018-2032 (USD MILLION)
  • TABLE 204. NATO IV FLUID BAGS MARKET SIZE, BY CRYSTALLOID, 2018-2032 (USD MILLION)
  • TABLE 205. NATO IV FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 206. NATO IV FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 207. NATO IV FLUID BAGS MARKET SIZE, BY BAG VOLUME, 2018-2032 (USD MILLION)
  • TABLE 208. NATO IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. NATO IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL IV FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES IV FLUID BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED STATES IV FLUID BAGS MARKET SIZE, BY COLLOID, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES IV FLUID BAGS MARKET SIZE, BY CRYSTALLOID, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES IV FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED STATES IV FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES IV FLUID BAGS MARKET SIZE, BY BAG VOLUME, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA IV FLUID BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA IV FLUID BAGS MARKET SIZE, BY COLLOID, 2018-2032 (USD MILLION)
  • TABLE 223. CHINA IV FLUID BAGS MARKET SIZE, BY CRYSTALLOID, 2018-2032 (USD MILLION)
  • TABLE 224. CHINA IV FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 225. CHINA IV FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA IV FLUID BAGS MARKET SIZE, BY BAG VOLUME, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)